You are currently viewing Continuous Glucose Monitor System Market Forecast Insights: The Road To $19.18 Billion By 2030
Continuous Glucose Monitor System Market Analysis

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Continuous Glucose Monitor System Market Value Growth And Long-Term Outlook#_x000D_

The continuous glucose monitor system market size has seen significant expansion in recent years. It is projected to rise from $9.6 billion in 2025 to $11.05 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.1%. This historical growth can be linked to the increasing prevalence of diabetes worldwide, a growing understanding of glucose self-monitoring, improvements in sensor accuracy and reliability, the expansion of outpatient diabetes management programs, and increased acceptance of wearable medical devices._x000D_

_x000D_

The continuous glucose monitor system market is projected to experience substantial expansion in the coming years. It is anticipated to reach $19.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.8%. This anticipated growth during the forecast period stems from factors such as the increasing embrace of closed-loop insulin delivery systems, a heightened need for remote patient monitoring, the development of personalized diabetes management options, enhanced integration with digital health platforms, and a greater emphasis on non-invasive glucose sensing. Significant developments expected in this period include the wider adoption of smartphone-integrated cgm systems, an increase in the utilization of real-time glucose monitoring solutions, the growing incorporation of AI-based glucose analytics, the proliferation of wearable sensor technologies, and a heightened commitment to continuous patient monitoring._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=78237208&type=smp&name=Continuous%20Glucose%20Monitor%20System%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Continuous Glucose Monitor System Market Opportunity Drivers: What’s Unlocking New Revenue Potential?#_x000D_

The increasing prevalence of diabetes is anticipated to propel the growth of the continuous glucose monitor system market moving forward. Diabetes is a chronic medical condition defined by high blood sugar levels, resulting from the body’s inability to produce or utilize insulin effectively. The rise in diabetes cases is primarily linked to factors such as increasing rates of obesity, unhealthy diets, physical inactivity, and an aging population. Continuous glucose monitoring (CGM) systems provide real-time glucose readings, assisting in diabetes management by detecting trends and alerting users to abnormal levels, thus improving glycemic control and minimizing the need for frequent finger pricks. For instance, in June 2024, the National Health Service, a UK-based government department, stated that in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marks a significant increase compared to 3,065,825 in 2022, indicating a rise of nearly 20%. Therefore, the increasing prevalence of diabetes is driving the growth of the continuous glucose monitor system market._x000D_

_x000D_

#Continuous Glucose Monitor System Market Segment Analysis And Revenue Potential#_x000D_

The continuous glucose monitor system market covered in this report is segmented – _x000D_

_x000D_

1) By Component: Transmitters, Receivers, Sensor_x000D_

2) By Technology: Real Time Continuous Glucose Monitoring, Intermittently Scanned Continuous Glucose Monitoring_x000D_

3) By Demography: Child Population, Adult Population_x000D_

4) By Application: Type-1 Diabetes, Type-2 Diabetes, Gestational Diabetes_x000D_

5) By End-User: Diagnostics Centers, Hospitals, Clinics, Intensive Care Unit (ICUs), Home Healthcare_x000D_

_x000D_

Subsegments:_x000D_

1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters _x000D_

2) By Receivers: Dedicated Devices (CGM Receiver), Smartphone-Based Receivers, Cloud-Connected Receivers _x000D_

3) By Sensor: Enzyme-Based Sensors, Non-Enzyme-Based Sensors, Electrochemical Sensors _x000D_

_x000D_

#Continuous Glucose Monitor System Market Innovation Trends Shaping Future Development#_x000D_

Leading companies within the continuous glucose monitor system market are prioritizing the development of advanced over-the-counter continuous glucose monitors (CGMs) to boost availability and broaden their reach among individuals who do not require a prescription. An over-the-counter (OTC) continuous glucose monitor (CGM) functions as a device that monitors glucose levels in real-time, eliminating the need for a prescription. It grants consumers straightforward and convenient access to independently track their glucose. For example, in September 2024, Abbott Laboratories, a medical device company based in the US, introduced Lingo in the United States. Designed for adults without diabetes, Lingo enables users to observe their glucose levels, offering valuable insights into how diet and exercise influence overall health. With a wearability of up to 14 days, this product aligns with Abbott’s strategy to capitalize on the growing segment of consumers focused on prediabetes management and wellness, all without needing a prescription._x000D_

_x000D_

#Continuous Glucose Monitor System Market Competitive Analysis Of Leading Industry Participants#_x000D_

Major companies operating in the continuous glucose monitor system market are Abbott Corporation, Medtronic PLC, Murata Manufacturing Co. Ltd., Dexcom Inc., Sinocare Inc., Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glooko Inc., DarioHealth Corp., Menarini Diagnostics SRL, Senseonics Holdings Inc., WaveForm Technologies Inc., Medtrum Technologies Inc., Biolinq Incorporated, Ultrahuman Inc., GlySens Incorporated, Glucotrack, EOFLOW CO. LTD., Nemaura Medical Inc., Meiqi Medical Equipment, Nipro Diagnostics UK Limited _x000D_

_x000D_

#View The Full Continuous Glucose Monitor System Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/continuous-glucose-monitor-system-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Continuous Glucose Monitor System Market Geographic Spread And Regional Opportunities#_x000D_

North America was the largest region in the continuous glucose monitor (CGM) system market in 2025. The regions covered in the continuous glucose monitor system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model